Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20056114HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20056220HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20024007HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS20039423HPVENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44008707HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44011238HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44033585HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44003748HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44018328HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TVIS44033529HTLV-1ENSG00000157542.11protein_codingKCNJ6NoNo3763P48051
TCGA Plot Options
Drug Information
GeneKCNJ6
DrugBank IDDB08954
Drug NameIfenprodil
Target IDBE0001030
UniProt IDP48051
Regulation Typeantagonist
PubMed IDs16123769
CitationsKobayashi T, Washiyama K, Ikeda K: Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil. Neuropsychopharmacology. 2006 Mar;31(3):516-24. doi: 10.1038/sj.npp.1300844.
GroupsInvestigational; Withdrawn
Direct Classification4-benzylpiperidines
SMILESCC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1
Pathways
PharmGKB
ChEMBLCHEMBL305187